Theme
Biotech '25: Neurology, CNS & Rare Disorders☆

ACOG+39.08%14.3%

MREO-9.96%14.3%

MTSR0.00%14.3%

RZLT+96.61%14.3%

SUPN-15.21%14.3%

VERA-41.29%14.3%

VYGR-39.69%14.3%
As of Oct 9, 2026, 4:27 AM ET
Biotech '25: Neurology, CNS & Rare Disorders Constituents
Alpha Cognition IncACOG | 14.3% | 0.00% | 5.12% | -0.99% | 3.91% | 39.08% | 50.67% | 77.95% | 19.42% | 7.62% | 7.62% | $140.4M |
Mereo BioPharma Group plcMREO | 14.3% | 6.35% | 1.41% | 54.40% | 2.23% | -9.96% | 1.24% | -84.17% | -82.13% | -90.98% | -82.79% | $59.9M |
Metsera, Inc.MTSR | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 47.04% | 0.00% | 85.11% | 85.11% | $3.51B |
Rezolute, Inc.RZLT | 14.3% | 5.94% | 11.00% | 14.29% | 14.00% | 96.61% | 44.55% | 53.64% | -47.45% | -2.93% | -37.47% | $446.8M |
Supernus Pharmaceuticals, Inc.SUPN | 14.3% | -2.11% | -5.52% | 0.17% | -0.09% | -15.21% | -23.00% | 28.40% | -14.89% | 29.66% | 59.80% | $2.45B |
Vera Therapeutics, Inc.VERA | 14.3% | -1.72% | -8.52% | -11.99% | -4.07% | -41.29% | -27.11% | 26.03% | -2.62% | -23.06% | 94.19% | $2.13B |
Voyager Therapeutics, Inc.VYGR | 14.3% | -4.05% | -12.22% | -27.08% | -11.57% | -39.69% | -42.20% | -30.50% | -53.98% | -66.53% | -57.30% | $143.2M |
| Theme return | — | 0.63% | -1.25% | -1.83% | -0.03% | 6.17% | 1.87% | 90.77% | 16.53% | 44.42% | 218.52% | — |
| Average | 14.3% | 0.63% | -1.25% | 4.11% | 0.63% | 4.22% | 0.59% | 16.91% | -25.95% | -8.73% | 9.88% | $1.27B |
| Median | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | -9.96% | 0.00% | 28.40% | -14.89% | -2.93% | 7.62% | $446.8M |
| Std Dev | 0.0% | 3.72% | 7.47% | 23.67% | 7.21% | 45.27% | 32.94% | 51.63% | 33.39% | 54.63% | 66.12% | $1.30B |
| Min | 14.3% | -4.05% | -12.22% | -27.08% | -11.57% | -41.29% | -42.20% | -84.17% | -82.13% | -90.98% | -82.79% | $59.9M |
| Max | 14.3% | 6.35% | 11.00% | 54.40% | 14.00% | 96.61% | 50.67% | 77.95% | 19.42% | 85.11% | 94.19% | $3.51B |
| % Positive Tickers | 28.57% | 42.86% | 42.86% | 42.86% | 28.57% | 42.86% | 71.43% | 14.29% | 42.86% | 57.14% |